Copyright © International Parkinson and Movement Disorder Society
Edited By: C. Warren Olanow, MD, FRCPC and Jose A. Obeso, MD, PhD
Impact Factor: 5.634
ISI Journal Citation Reports © Ranking: 2013: 14/194 (Clinical Neurology)
Online ISSN: 1531-8257
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
MANUSCRIPT SUBMISSION INFORMATION
NOTE: As of January 2014, Movement Disorders no longer accepts submissions for Clinical Vignettes or Medical Images. These types of articles may be submitted to Movement Disorders Clinical Practice at: http://mc.manuscriptcentral.com/mdcp
Movement Disorders is pleased to offer authors web-based manuscript submission and peer-review
Authors are required to submit online at http://mc.manuscriptcentral.com/mds. All accompanying supplementary material (e.g., videos, appendices) should also be submitted online.
Policy Regarding Inappropriate Submissions and Publications
The editors, members of the editorial board, and publisher's staff at Movement Disorders take their responsibility seriously to assure that the highest ethical publishing standards are maintained by assisting in safeguarding the medical scientific literature against fraudulent publications. Please note manuscript submissions are now submitted for plagiarism detection through CrossCheck. Wiley-Blackwell policy is based on the 'Guidelines on Good Publication Practice' published by the Committee on Publication Ethics (COPE) and can be found at Author Services.
Examples of fraud in scientific research include (but are not limited to):
1) The submission of duplicate publications using similar data (i.e., attesting that work submitted is original when, in fact, it was submitted to or accepted by another journal);
2) Falsification of data, copyright, or information regarding conflict of interest;
3) Submission of work from other sources that was not done by the author and is presented as a new and original (plagiarism);
4) Authorship (allowing one’s name to appear as an author or adding an author to a manuscript) without substantial input or without having agreed to submission of the manuscript.
The above examples are not meant to be a comprehensive list of fraudulent publication practices. Rather, it should provide adequate basis for careful consideration of avoidable conflicts and editorial scrutiny regarding inappropriate preparation and submission of manuscripts.
Manuscripts that have appeared in publications that are not peer-reviewed, are not registered in Pub Med, or are available only on the internet, will be considered for publication in MDS as long as the Editor is informed and grants approval prior to submission of the manuscript for review. If there are questions as to any issues regarding inappropriate submission, the Editor should be consulted prior to the submission. If a submitted or published manuscript is discovered or suspected to be inappropriate, the authors will be asked for a written explanation. If the rationale provided by the authors remains unsatisfactory in the judgment of the editors, the manuscript will be rejected or retracted. Retractions become a matter of public record and are registered in Pub Med. The provost (or equivalent) of the authors' academic institutions will be informed of inappropriate submissions or publications, and the authors will not be allowed to subsequently submit their research to MDS. The leadership of MDS will also inform the editors and publishers of other journals which have published manuscripts judged to be inappropriately submitted to MDS.
Editorial Office Information
Jose A. Obeso, MD, PhD
University of Navarra
Phone: 34-948-194700, ext. 2038
C. Warren Olanow, MD, FRCPC
Mount Sinai School of Medicine
New York, New York, USA
Submit your manuscripts online at http://mc.manuscriptcentral.com/mds. Please note:Manuscripts submitted online are marked as received on the day of submission, evaluated by the Chief Editors, and assigned to associate editors to oversee the review process. Papers that are not determined to be of sufficient clinical/scientific interest, focus, or relevance by at least two senior editors may be rejected without review. Through your individual Author Center on this website, you can view the status of your manuscript as it progresses through the review process. Notification of the final disposition of each manuscript will be sent by e-mail to the corresponding author on the day of decision.To submit your manuscript online:
- Go to the submission website (http://mc.manuscriptcentral.com/mds)
- Click on the "Check for Existing Account" button at the bottom of the opening page. If you do not already have an account, then create one by clicking on the "Create an Account" button. You will then be able to submit your manuscript.
- Click on “Author Center.” Follow the on-screen instructions carefully. Tables and figures should be uploaded as individual files and not part of the manuscript text. (You do not need to mail hard copies of your manuscript).
- At the end of a successful submission, you will see a confirmation screen with your manuscript number, and you will receive a separate E-mail confirmation of manuscript reception by the journal. If these two messages do not appear, then go into your Author Center and make sure that you have clicked on the “Submit” button or contact technical support at http://mchelp.manuscriptcentral.com/gethelpnow/question.htm
General Information: When submitting manuscripts online, authors must indicate whether the article has an accompanying video. Video must be submitted with manuscripts online in a digital format. If an article includes video, the upper right corner of the title page of the manuscript must be marked “Video is part of ms.” Video clips should be limited to 90 seconds unless formal approval is obtained from the editorial office. Authors must also supply, as part of the manuscript, a video legend for the video clip. If the author does not have the capacity to generate an electronic video, the author may contact the editorial office for assistance.
Content: Video content should be edited to illustrate the key findings in a concise and informative manner. They should be less than 90 seconds in duration, except for special instances, which must be cleared in advance with the appropriate chief editor. Legends for the video segments should be placed at the end of the article and should concisely and sequentially describe what is seen in the video so that it can be readily understood by the viewer. Do not repeat explanatory material that is already in text. The video should be of high quality (both in content and visibility). The video should be edited to ensure maximal efficiency and make the specific point; particularly, it should demonstrate the features described in the text of the manuscript. In addition, the video should be labelled and should directly follow the sequence and content of the video legend.The use of text and/or special transition effects between the titles, subtitles and video segments is permitted. The video you submit should be the final product that will be published with the article. The Editors reserve the right to request additional video editing by the authors (which may delay publication).
Patient Consent: The corresponding author must confirm in the author copyright form (Article V) that he or she has received a signed release form from each patient videotaped authorizing the offline and/or online distribution of this video material. Manuscripts with videos will not be sent out for review until the signed copyright form (Article V) with appropriate documentation is received. The date of submission will be the date all components of the article arrive at the editorial office.
For tips on preparing your video for submission, see the Technical Note by Jog and Grantier on digital video preparation. This article appears in volume 16, issue 6, and is available to all readers.
Cover Letter, Author Copyright Form, and Legal Information
Cover Letter. The cover letter should briefly describe the scientific or clinical importance of the manuscript. It must confirm that all authors have read the manuscript, the paper has not been previously published, and it is not under simultaneous consideration by another journal. Also, a statement that no ghost writing by anyone not named on the author list must be included (see Editorial in Movement Disorders 2005;20:1536). Identify the corresponding author and provide a complete mailing address, telephone number, and email address for each author where possible.
Author Copyright Form. The author Copyright form includes (1) a statement on authorship responsibility, (2) a statement on financial disclosure, (3) one of two statements on copyright or federal employment, and (4) a statement of acknowledgment. Each of the first three statements must be read and signed by each co-author. The corresponding author must sign the acknowledgment statement (See the copyright form at the top of this page).:5) When there is accompanying video or photographs on which patients can be identified, the corresponding author must sign the video consent section (Article V).
Group Authorship. The journal does not limit the number of authors for an individual manuscript providing that: a)If there are multiple authors , all authors must meet the full criteria and requirements for authorship; b). If there is group, authorship, one or more individuals are designated as authors or members of a writing group who meet full authorship criteria and who take responsibility for the group. Other members of the group are not authors individually, but may be listed in the acknowledgment section (Flanagin A, Fontanarosa PB, DeAngelis CD. Authorship for research groups. JAMA 2002;288:3166-3168).
Documentation of Author Roles. At the end of the manuscript, all authors must be listed, along with their specific roles in the project and manuscript preparation. These should include but not be restricted to:
1. Research project: A. Conception, B. Organization, C. Execution;
2. Statistical Analysis: A. Design, B. Execution, C. Review and Critique;
3. Manuscript Preparation: A. Writing of the first draft, B. Review and Critique;
Data Access and Responsibility. For clinical trials sponsored by pharmaceutical companies, authors must state in their letter of submission that (1) they have had full access to the data, (2) they have the right to publish all the data, and (3) they have had the right to obtain independent statistical analyses of the data. For any report containing original data, at least one author should indicate that he or she “takes responsibility for the integrity of the data and the accuracy of the data analysis” (DeAngelis CD, Fontanarosa PB, Flanagan A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001;286:89-91).
Patient Consent. When submitting a patient video or photograph in which a patient can be identified, the corresponding author must provide the Movement Disorders journal with a written confirmation (author copyright form, Article V) that stipulates that authorization signed by the patient has been obtained in compliance with any laws regarding patient authorizations relating to the use or disclosure of protected health information of the jurisdiction(s) to which the patient and the physician are subject including, if applicable, the United States Health Insurance Portability and Accountability Act of 1996 (“HIPAA”).1 Manuscripts including, without limitation, a patient video or photograph will not be reviewed until a signed author's accompanying statement (see Item V) has been received.
Copyright. The International Parkinson and Movement Disorder Society will hold copyright to all published articles and videos.
The copyright transfer agreement form can be downloaded from the top of this page. If you are a government employee, please check the “Government-Owned Work” checkbox.
Financial Disclosures. All submissions require two entries that cover financial disclosure of all authors:
§ Financial disclosure related to research covered in this article: A statement that documents all funding sources and potential conflicts of interest from each author that relate to the research covered in the article submitted must be included on the title page, regardless of date. This material will be printed with the published article.
§ Full financial disclosure for the previous 12 months: A statement that documents all funding sources, regardless of relationship to the current research in the article, from each author must be attached to the article at the end of the manuscript on the last page. This material will be posted on the journal website and may be printed at the Editors’ discretion.
The copyright form that is signed by each author confirms that both of these entries are documented in the submitted material.
Expedited Publications (Fast Track)
Movement Disorders will attempt to accommodate authors of manuscripts dealing with extremely topical issues or with findings of great scientific or clinical importance by offering Expedited Review and Publication. Expedited papers will be rapidly reviewed and published within 8 weeks.
Movement Disorders publishes Full-length Articles, Reviews, Opinion papers/Viewpoints/Hypotheses/Editorials, Brief Reports, and Letters. All articles in Movement Disorders, including letters, can be accompanied by a video when appropriate.
Authors who are not perfectly fluent in English should have their manuscript professionally edited before submission. A list of independent suppliers of editing services can be found at www.blackwellpublishing.com/bauthor/english_language.asp. Japanese authors can also find a list of local English improvement services at http://www.wiley.co.jp/journals/editcontribute.html. All services must be arranged and paid for by the author, and use of one of these services does not guarantee acceptance for publication. In addition, the journal will edit accepted papers to ensure uniformity of language and style.
- Full-Length Articles: Full-length articles should present new clinical or scientific data in a field related to movement disorders. The format should include - Structured Abstract (up to 250 words with only essential abbreviations (e.g. DNA)). Text; (up to 3000 words exclusive of abstract, legends, and references) Minimize abbreviations. Tables and/or figures – up to 5.. Legends; should be concise and describe results without repeating data in text. Videos; see above. The word count must appear on the title page. Reviews:Clinical and basic science Reviews are generally published upon request or after agreement with the editors of Movement Disorders. Unsolicited Reviews will also be considered for publication. Reviews can be up to 3600 words. The word count must appear on the title page.
- Scientific Perspectives: The purpose of these articles is to discuss recent important scientific results and methodologies and to place them into a clinical and translational context. Length should be no more than 5000 words, and color figures and tables can be included. These will have priority in review and production, with a goal of publication within 6 weeks of submission. Scientific Perspectives are generally published upon request or after agreement with the editors. Proposals for topics and other inquiries may be directed to the Scientific Perspectives Editor (firstname.lastname@example.org).
- Viewpoints, Hypotheses, Editorials: Editorials are solicited by the editors. Hypotheses and viewpoints related to any aspect of movement disorders may be submitted without solicitation. Viewpoints, Hypotheses/Editorials should be limited to 2000 words and 50 references. The word count must appear on the title page.
- Brief Reports:Brief reports are short original clinical or basic science reports related to any aspect of movement disorders. Structured Abstracts up to 150 words, text up to 1500 words, tables and figures up to 2. References should be limited to 40. The word count must appear on the title page.
- Case reports are not normally recommended for consideration as a research article or brief report and should be submitted as a letter unless they make a scientifically important point.
- Letters to the Editors should have no more than five authors. Movement disorders permits publication of two types of letters to the editor with no abstract:
- A)Letters related to new observations. This section is appropriate for preliminary scientific observations and case presentations that raise a novel clinical or scientific issue. Letters on new observations may be up to 500 words and contain no more than 1 table/figure and 7 references.
- B) A letter related to published articles. These may be submitted up to 8 weeks after the paper was published in print. Text length for both letters and replies may be up to 500 words and contain 1 table/figure and up to 5 references. Letters from original authors must be submitted within 4 weeks after request for response.
- Articles reporting Clinical Trials: Clinical Trial Reports must be written in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement (Moher D et al., JAMA 2001;285:1987–1991; see also Moher D et al., Lancet 2001;357:1191–1194). Authors should ensure that information on all of the critical design features listed in the CONSORT checklist is reported in the manuscript. A CONSORT flow diagram should be included with the manuscript, clearly outlining the flow of patients through the trial. In addition, a statement is required in the cover letter specifically confirming that there has been no ghost writing by anyone not named on the author list (see Editorial in Movement Disorders 2005;20:1536). The precise financial relationship between a clinical trial sponsor and the authors must be delineated in the manuscript.
Form of Manuscripts.
The text of the manuscript should be in the following sequence: (1) Title page, (2) Abstract, (3) Introduction, (4) Methods, (5) Results, (6) Discussion, (7) Acknowledgment, (8) Authors' Roles, (9) Financial Disclosures of all authors (for the preceding 12 months), (10) References, (11) Video Legend, (12) Figures, and (13) Tables. Pages should be numbered in succession, the title page being number one.
Title: Titles should be short, specific, and clear. They should not exceed 100 characters. Do not use abbreviations/acronyms in the title.
Title Page:The opening page of each manuscript should include: (1) article title (no abbreviations/acronyms); (2) authors' names and affiliations (indicate the specific affiliation of each author by superscript, Arabic numerals); (3) name, address, telephone and email address of the corresponding author; (4) word count; (5) a running title not exceeding 45 letters and spaces; (6) Key words – up to 5; (7) Financial Disclosure/Conflict of Interest concerning the research related to the manuscript: All information on support and financial issues from all authors relative to the research covered in the submitted manuscript must be disclosed regardless of date. Other financial information unrelated to the current research covering the past year will be documented at the end of the manuscript (see below). (8) Funding sources for study.
Structured Abstract: We require that authors submit structured abstracts, but will consider unstructured abstracts if requested by the authors prior to submission. The page following the title page of Full-Length Articles, and Reviews, should include an abstract of up to 250 words. The abstract should be structured (background, methods, results, and conclusions) unless not appropriate for a specific article. The page following the title page of a Brief Report, should include a structured abstract of up to 150 words. Authors are required to spell out all abbreviations/acronyms in the structured abstract unless this has become accepted in the standard scientific literature (e,g, DNA, MPTP).
Introduction: Give a brief description of the background and relevance of the scientific contribution.
Methods: Describe the methodology of the study. For experimental investigation of human or animal subjects, please state in this section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees, the principles outlined in the “Declaration of Helsinki” should be followed. For investigations in human subjects, state in this section the manner in which informed consent was obtained from the subjects. A letter of consent must accompany all photographs, patient descriptions, and pedigrees in which a possibility of identification exists. The authors are responsible for ensuring anonymity.
Results: No specific regulations.
Discussion: No specific regulations.
Acknowledgment: No specific regulations. These may be published on line at the discretion of the editor.
Author Roles: List all authors along with their specific roles in the project and preparation of the manuscript. These may include but are not restricted to: 1) Research project: A. Conception, B. Organization, C. Execution; 2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; 3) Manuscript: A. Writing of the first draft, B. Review and Critique.
Full Financial Disclosures of all Authors for the Past Year: Information concerning all sources of financial support and funding for the preceding twelve months, regardless of relationship to current manuscript, must be submitted with the following categories suggested. List sources or “none”.
Stock Ownership in medically-related fields
Intellectual Property Rights
References: See “Details of Style” below for the proper formatting of citations and References.
Video Legend: No specific regulations but should be concise and reflect the sequence of observations on the video
Tables and Figure Legends: Double-space legends of fewer than 40 words for tables and figures. For photomicrographs, include the type of specimen, original magnification, and stain type. Include internal scale-markers on photomicrographs when appropriate. Where applicable, indicate the method used to digitally enhance images.
Tables: Tables should be typed neatly, each on a separate page, with a title above and any notes below. Explain all abbreviations. Do not repeat the same information in tables and figures that is present in text.Tables and figures should be uploaded as individual files and not part of the manuscript text. (You do not need to mail hard copies of your manuscript).
Figures and Illustrations: Adapt any figures to an appropriate size of art and letters to make them readable in the printed version. Illustrations in full color are accepted at additional charge from the publisher. In the case of review articles or in special circumstances, color articles may be included at no charge with the permission of the Chief Editor. Any illustration or figure from another publication must be acknowledged in the figure legend, and the copyright holder’s written permission to reprint in print and online edition of Movement Disorders must be submitted to the editors. In addition, figures to illustrate concepts are welcome particularly in review articles, and may be enhanced by a professional artists at no cost to author at the discretion of the Editors.
Copyright and Disclosure Forms The corresponding author should upload one PDF file that includes copyright and disclosure forms for all authors to the Movement Disorders submission site with the revised version of the paper. These forms also can be emailed to email@example.com.
Digital Artwork Preparation
For best reproduction, electronic artwork files must be in TIFF or EPS format, at a resolution of 600 dpi or higher, sized to print. Movement Disorders offers Rapid Inspector™ to help ensure that your electronic graphics files are suitable for print purposes. This free, stand-alone software application will help you to inspect and verify illustrations right on your computer. Go tohttp://rapidinspector.cadmus.com/wi/index.jsp and create a new account. JPG files are of low resolution and will not be acceptable for publication.
Details of Style
No patient identifiers (e.g., patient initials) are to be included in the manuscript or video (e.g., case reports, tables, figures, etc.).
Units of measure: Conventional units of measure according to the Systeme International (SI) are preferred. The metric system is preferred for length, area, mass, and volume. Express temperature in degrees Celsius.
Drug Names: Use generic names only in referring to drugs, followed in parentheses after first mention by any commonly used generic variant.
Abbreviations: Follow the list of abbreviations given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (see section on References). For additional abbreviations, consult the CBE Style Manual (available from the Council of Biology Editors, 9650 Rockville Pike, Bethesda, Maryland 20814, USA) or other standard sources. We encourage authors to minimize the use of abbreviations except where they are routinely employed and the full term would be cumbersome (eg MPTP).
Spelling: American spelling is used throughout the Journal.
Movement Disorders complies with the reference style given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals". (See Annals of Internal Medicine 1982;96:766-771, or British Medical Journal 1982:284:1766-1770.)
References are to be cited in the text by number, and in the list of References they are to be numbered in the order in which they are cited. The reference section should be double-spaced at the end of the text, following the sample formats given below. Provide all authors' names when fewer than seven; when seven or more, list the first three and add et al. Provide article titles and inclusive pages. Accuracy of reference data is the responsibility of the author. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus (available from the Superintendent of Documents, U.S. Government Printing Office, Washington DC 20402, USA, DHEW Publication No. (NIH) 83-267; ISSN 0093-3821).
· Journal article:
1. Krack P, Benzzzouz A, Pollak P, et al. Treatment of tremor in Parkinson’s disease by Subthalamic nucleus stiumulation. Mov Disord 1998; 13: 907-914.
2.Fahn S, Jankovic J, editors. Principles and Practice of Movement Disorders, Philadelphia, Churchill Livingstone, 2010, pp 96.
· Chapter in a book:
3. Olanow CW. Hpyerkinetic Movement Disorders. In: Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson JL, Loscalzo J. Eds. Harrison’s Textbook of Medicine 17th edition. 2008; p2560-2565.
Accepted Articles: Materials Required for Publication
After acceptance, please check to be sure that you have submitted your signed copyright transfer and author consent form as well as permissions forms (if applicable). Authors using images of their patients, whether in artwork or video format, must submit a copy (signed by the corresponding author) of the copyright transfer and author consent form. A sample form is available to authors on Manuscript Central.
Proofs must be returned within 3 days of receipt; late return may cause a delay in publication of an article. Please check text, tables, legends, and references carefully. To expedite publication, page proofs rather than galleys will be sent electronically to the author, and it may be necessary to charge for alterations other than correction of printing errors.
E-mail proof pages to: MDS Production Editor, Movement Disorders. E-mail: firstname.lastname@example.org.
For Video Clips or Pictures of Patients (U.S. Contributors Only): The United States Health Insurance Portability and Accountability Act of 1996 (“HIPAA”)
According to HIPAA, the following core elements must be included in the consent form:
1. A specific and meaningful description of the information to be used
2. The name of the Physician and/or Hospital allowed to disclose the information
3. That the video clip and/or photograph will be submitted for publication in a peer-reviewed medical journal
4. That the video clip and/or photograph will eventually be used by the readers of a peer-reviewed medical journal for educational purposes
5. An expiration date that relates to the individual or the purpose of the use or disclosure
6. The individual’s signature and the date the authorization is signed.
In addition, the patient’s consent form should include the following:
1. A statement that the Patient has the right to revoke his or her consent in writing
2. A statement regarding whether the Physician has the ability to condition medical treatment on the Patient’s giving such consent
3. A statement that information, once disclosed, may be subject to further disclosure by the recipient journal, in which case confidentiality would no longer be assured. The consenting party must understand, additionally, that in some cases the video might be re-presented elsewhere because the journal has policies that allow permissions and/or use copyrighted materials with other educational organizations. The consenting party must understand that in such a case the signed author’s consent form may be shared with this third party and the consenting party consents to this sharing of information for educational purposes.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, seehttp://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://onlinelibrary.wiley.com/onlineOpenOrder.
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Color and Page Charges
All figures accepted in color will be reproduced in full color in the online edition of the journal at no cost to authors. Authors are required to pay the cost of reproducing color figures in print. The cost for the first page of color is $950. Color agreement forms will be sent in conjunction with the PDF proofs. Authors are not required to pay for printed pages, except in the cases of errata. For errata due to publisher error, there is no page charge. For errata due to author error, the charge to the author is $150 per printed page.